Delirium tremens: Difference between revisions
Line 101: | Line 101: | ||
* Serum levels of following electrolytes | * Serum levels of following electrolytes | ||
** Sodium | ** Sodium | ||
** Potassium | ** Potassium | ||
** Chloride | ** Chloride | ||
** Bicarbonate | ** Bicarbonate | ||
** Blood urea nitrogen (BUN) | ** Blood urea nitrogen (BUN) | ||
** Creatinine | ** Creatinine | ||
** Magnesium | ** Magnesium | ||
** Phosphorous | ** Phosphorous | ||
** Liver function tests | ** Liver function tests | ||
** Creatine phosphokinase - Some patients develop rhabdomyolysis | ** Creatine phosphokinase - Some patients develop rhabdomyolysis | ||
** Lipase | ** Lipase | ||
** Ketones | ** Ketones | ||
Revision as of 19:28, 11 August 2012
For patient information, click here
Delirium tremens | |
ICD-10 | F10.4 |
---|---|
ICD-9 | 291.0 |
DiseasesDB | 3543 |
MedlinePlus | 000766 |
MeSH | D000430 |
WikiDoc Resources for Delirium tremens |
Articles |
---|
Most recent articles on Delirium tremens Most cited articles on Delirium tremens |
Media |
Powerpoint slides on Delirium tremens |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Delirium tremens at Clinical Trials.gov Trial results on Delirium tremens Clinical Trials on Delirium tremens at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Delirium tremens NICE Guidance on Delirium tremens
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Delirium tremens Discussion groups on Delirium tremens Patient Handouts on Delirium tremens Directions to Hospitals Treating Delirium tremens Risk calculators and risk factors for Delirium tremens
|
Healthcare Provider Resources |
Causes & Risk Factors for Delirium tremens |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: the horrors; rum fits; the shakes; shaking delirium; trembling madness; DT's
Overview
Delirium tremens is an acute episode of delirium that is usually caused by withdrawal or abstinence, from alcohol following habitual excessive drinking, or benzodiazepines or barbiturates (and other major tranquilizers).
Pathophysiology
Delirium tremens can also appear after a rapid reduction in the amount of alcohol being consumed by heavy drinkers, or a rapid reduction of intake of benzodiazepines or barbiturates. Caused by alcohol, it only occurs in individuals with a history of constant, long-term alcohol consumption. Occurrence due to benzodiazepine or barbiturate withdrawal does not require as long a period of consistent intake of such drugs. Prior use of both tranquilizers and alcohol can compound the symptoms, and while extremely rare, is the most dangerous especially if untreated. Barbiturates are generally accepted as being extremely dangerous, both due to overdose potential and addiction potential including the extreme withdrawal syndrome that usually is marked by delirium tremens upon discontinuation.
The exact pharmacology of ethanol is not fully understood: however, it is theorized that delirium tremens is caused by the effect of alcohol on the benzodiazepine-GABAA-chloride receptor complex for the inhibitory neurotransmitter GABA. Constant consumption of alcoholic beverages (and the consequent chronic sedation) causes a counterregulatory response in the brain in attempt to re-achieve homeostasis. This causes downregulation of these receptors, as well as an up-regulation in the production of excitatory neurotransmitters such as norepinephrine, dopamine, epinephrine, and serotonin - all of which further the drinker's tolerance to alcohol and may intensify tonic-clonic seizures. When alcohol is no longer consumed, these down-regulated GABAA receptor complexes are so insensitive to GABA that the typical amount of GABA produced has little effect; compounded with the fact that GABA normally inhibits action potential formation, there are not as many receptors for GABA to bind to - meaning that sympathetic activation is unopposed. This is also known as an "adrenergic storm".
This is all made worse by excitatory neurotransmitter upregulation, so not only is sympathetic nervous system over-activity unopposed by GABA, there is also more of the serotonin, norepinephrine, dopamine, epinephrine, and particularly glutamate. Excitory NMDA receptors are also upregulated, contributing to the delirium and neurotoxicity (by excitotoxicity) of withdrawal. Direct measurements of central norepinephrine and its metabolites is in direct correlation to the severity of the alcohol withdrawal syndrome.
Causes
Differentiating Delirium Tremens from other Disease
Delirium tremens (DT) should be distinguished from alcoholic hallucinosis, the latter occurring in approximately 20% of hospitalized alcoholics and not carrying a significant mortality. In contrast, DT occurs in 5-10% of alcohol-dependent people and carries up to 5% mortality with treatment and up to 35% mortality without treatment. DT is characterized by the presence of altered sensorium; that is, a complete hallucination without any recognition of the real world. DT has extreme autonomic hyperactivity (high pulse, blood pressure, and rate of breathing), and 35-60% of patients have a fever. Some individuals experience seizures as well..
Epidemiology and Demographics
Five percent of acute ethanol withdrawal cases progress to delirium tremens. Unlike the withdrawal syndrome associated with opiate addiction (generally), delirium tremens (and alcohol withdrawal in general) can be fatal. Mortality can be up to 35% if untreated; if treated early, death rates range from 5-15%.
Risk Factors
- Head injury
- CNS infection
- Sepsis
- Drug abuse
- Malnutrition
- Alcoholism that has existed for more than 10 years
Screening
- Screening tools include the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and the CAGE screening test
Natural History, Complications and Prognosis
Complications
Adrenergic storm causes a few complications which include (but are not limited to)
Diagnosis
Symptoms
The main symptoms are
Other common symptoms include
- Intense hallucinations - formication
- Tremors
- Anxiety
- Panic attacks
- Paranoia
Physical Examination
Appearance of the Patient
Diaphoresis, severe psychomotor agitation
Vital Signs
- Temperature - Hyperthermia
- Pulse - Tachycardia
- Blood pressure - Hypertension
- Respiratory rate - Tachypnea
Neurologic
Eye
Laboratory Findings
Electrolyte and Biomarker Studies
- Complete blood count, differential count
- Drug screening
- Blood lactate levels
- Osmolal gap
- Serum levels of following electrolytes
- Sodium
- Potassium
- Chloride
- Bicarbonate
- Blood urea nitrogen (BUN)
- Creatinine
- Magnesium
- Phosphorous
- Liver function tests
- Creatine phosphokinase - Some patients develop rhabdomyolysis
- Lipase
- Ketones
Electrocardiogram
- To evaluate any electrolyte abnormalities causing electro physiological changes in heart muscle.
Chest X Ray
- To evaluate any associated chest infections
Treatment
Pharmacotherapy is symptomatic and supportive. Typically the patient is kept sedated with benzodiazepines, such as diazepam (Valium), lorazepam (Ativan) or oxazepam (Serax) and in extreme cases low-levels of antipsychotics, such as haloperidol until symptoms subside. Acamprosate is often used to augment treatment, and is then carried on into long term use to reduce the risk of relapse. If status epilepticus is present, seizures are treated accordingly. Controlling environmental stimuli can also be helpful, such as a well-lit but relaxing environment to minimise visual misinterpretations such as the visual hallucinations mentioned above.
References
See also
da:Delirium tremens de:Delirium tremens et:Delirium tremens hu:Delirium tremens nl:Delirium tremens (ontwenningsverschijnsel) nn:Delirium tremens sl:Alkoholni delirij sr:Делиријум тременс fi:Delirium tremens sv:Delirium tremens